V
Weakening
Earnings & Expectation Momentum is the strongest tailwind right now
55.0 · Lean Bullish
Swing Rank 47.93
Price: $361.52
Since added: -2.1%
Added
Typically 2-6 weeks (BullYeah's Swing horizon window)
Trade Map
Fixed-ATR house convention · not personalized advice
Invalidation
350.68
350.68
Stop-loss level, -3.0% from entry. A close below this price invalidates the setup - the thesis is considered wrong, not just “down for now.”
Entry Zone 359.66–363.38 - the house-convention buy range for this setup, not a single exact price.
$361.52
Current price - where V is trading right now relative to the full Invalidation-to-Target2 range.
T1 377.78
Target 1, 1.5:1 reward-to-risk from entry. First profit-taking level.
T2 394.04
Target 2, 3.0:1 reward-to-risk from entry. Extended target for the stronger case.
Entry Zone
A price range (not one exact number) considered a reasonable place to start a position - real markets tick around too much to nail an exact entry price.
359.66–363.38
Invalidation
The price at which the original reason for a trade is considered wrong - if price reaches it, the setup is invalidated and the honest move is to exit, not hope.
350.68 (-3.0%)
Target 1
How much upside you're targeting compared to how much you're risking. A 2:1 ratio means the target is twice as far away as the stop - so you can be wrong more often than right and still come out ahead.
377.78 (1.5:1)
Target 2
394.04 (3.0:1)
Conviction Breakdown
Tailwinds
Earnings & Expectation Momentum+5.1
Business Quality & Fundamentals+3.1
Trend+1.8
Momentum+0.7
News & Catalysts+0.6
Headwinds
Market & Sector Regime-3.1
Valuation-1.5
Signed Volume & Order Flow-0.6
Score History
Scores are for informational purposes only and do not constitute financial or investment advice.
BullYeah Swing Rank and the trade levels above are general, rules-based outputs of BullYeah's own methodology - not individualized investment advice and not tailored to your financial circumstances, portfolio, or risk tolerance. Past performance is not a guarantee of future results.